Skip to main content
Clinical Trials/NCT02557165
NCT02557165
Unknown
Not Applicable

Impact of Chronic Obstructive Pulmonary Disease on Peripheral and Respiratory Muscle Regeneration

Laval University0 sites27 target enrollmentJanuary 2011
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Laval University
Enrollment
27
Primary Endpoint
Muscle satellite cell proliferation index
Last Updated
10 years ago

Overview

Brief Summary

Muscle weakness and atrophy are important consequences of chronic obstructive pulmonary disease (COPD) and can affect both respiratory and peripheral muscles. Impaired muscle regeneration is thought to be implicated in the process of muscle atrophy. In this study the investigators will evaluate muscle regenerative potential of the Vastus Lateralis (VL) and diaphragm of patients with COPD, compared to patients with normal lung function.

Detailed Description

Preliminary results suggest that the activation and differentiation processes of satellite cells isolated from the VL of patients with COPD could be altered. The investigators propose to compare the regenerative potential of the VL and the diaphragm in 15 patients with COPD and 15 individuals with normal lung function undergoing a thoracic surgery. From muscle biopsies, satellite cells will be isolated and cultured to assess their proliferation and differentiation rates, and the expression level of myogenic effectors (MyoD, Myf5, myogenin, and MRF4). Alterations in these measurements will confirm the hypotheses that the regenerative potential is lower in both muscle groups in patients with COPD compared to controls and that in COPD, the regenerative potential is lower in VL compared to the diaphragm.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
December 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with a scheduled thoracic surgery
  • ≥ 40 years
  • Smoking cessation ≥ 1 month
  • Smoking history ≥ 10 pack-year

Exclusion Criteria

  • Subjects who received either chemiotherapy or radiotherapy
  • Hypoxemia
  • Body weight loss ≥ 10%
  • Use of systemic corticosteroid in the last month

Outcomes

Primary Outcomes

Muscle satellite cell proliferation index

Time Frame: Sequential analyses performed over a period of 2 weeks after tissue collection.

Isolation from muscle biopsies of satellite cell to evaluate their regeneration capacity by evaluating the proliferation capacity

Muscle satellite cell differentiation index

Time Frame: Sequential analyses performed over a period of 2 months after tissue collection.

Isolation from muscle biopsies of satellite cell to evaluate their regeneration capacity by evaluating the differentiation capacity

Similar Trials